Harmony Biosciences (NASDAQ:HRMY) reported its Q4 earnings results on Monday, February 28, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Harmony Biosciences beat estimated earnings by 70.27%, reporting an EPS of $0.63 versus an estimate of $0.37.
Revenue was up $34.92 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.23 which was followed by a 1.02% increase in the share price the next day.
Here's a look at Harmony Biosciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.28 | 0.18 | -0.03 | 0.09 |
| EPS Actual | 0.51 | 0.54 | 0.38 | 0.25 |
| Revenue Estimate | 79.85M | 68.77M | 57.07M | 51.85M |
| Revenue Actual | 80.73M | 73.82M | 59.67M | 56.29M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
